Qkine appoints European distribution partner CliniSciences
Qkine is pleased to announce a new sales distribution agreement with industry-leading European distributor, CliniSciences.
News
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
Qkine shortlisted for the Business Weekly Awards 2023
Qkine is excited to be shortlisted for the Business Weekly Awards 2023 alongside scaling and inspirational companies in the Cambridge cluster.
Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production
Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production
Qkine appoints Indian distribution partner Biogenuix
Qkine is delighted to extended its global reach by agreeing a new sales distribution agreement with Biogenuix, an Indian distribution partner.
Qkine announces new partnership with Sartorius
Qkine is delighted to announce its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.
Qkine officially opens new HQ and expanded manufacturing facility in Cambridge, UK
On Friday, 28th April 2023, Qkine officially opened its new HQ at Murdoch House, Cambridge, UK. We were delighted to be joined by Mayor Dr. Nik Johnson, the Mayor of Cambridge & Peterborough, alongside our team, customers, investors, and representatives from the Cambridge ecosystem.
New phase of growth as Qkine relocates into state-of-the-art facility
New phase of growth as Qkine relocates into state-of-the-art facility A Q&A with Dr.
Qkine is a Cofinitive #21toWatch Top21.2023 winner!
Qkine is excited to be a Top21.2023 winner in this year’s Cofinitive #21toWatch awards.
Qkine raises over £4M to scale manufacturing, R&D and commercial functions
Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M.
Designing biomimetic neural materials for scalable 3D cell culture
In conjunction with the LifETIME CDT program, Qkine has sponsored a PhD studentship based at Aston University, Birmingham, UK. Martha Gallagher started her PhD in Professor Eric Hill’s lab to develop a 3D biomaterial scaffold that will display multiple neurodevelopmental signalling factors to mimic corticogenesis with induced pluripotent stem cell-derived neurons and glia.
Qkine and 3D Bio-Tissues collaboration awarded €100,000 at EIT Food Venture Summit 2022
A collaboration between Qkine and 3D Bio-Tissues has been awarded one of four prestigious prizes at the 2022 EIT Food Venture Summit, held in Lisbon, Portugal. Prize money will be used to develop new solutions to reduce the cost of cultivated meat.
